HomeABOS • NASDAQ
add
Acumen Pharmaceuticals Inc
Previous close
$3.17
Day range
$3.15 - $3.29
Year range
$1.81 - $5.09
Market cap
196.46M USD
Avg Volume
198.26K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.85M | 11.58% |
Net income | -20.54M | -76.89% |
Net profit margin | — | — |
Earnings per share | -0.34 | -21.43% |
EBITDA | -24.36M | -80.97% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 260.47M | 79.78% |
Total assets | 288.91M | 62.86% |
Total liabilities | 44.97M | 427.09% |
Total equity | 243.95M | — |
Shares outstanding | 60.08M | — |
Price to book | 0.78 | — |
Return on assets | -20.67% | — |
Return on capital | -21.53% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -20.54M | -76.89% |
Cash from operations | -16.54M | -41.77% |
Cash from investing | 37.70M | 240.74% |
Cash from financing | -128.00K | 11.72% |
Net change in cash | 21.03M | 2,899.73% |
Free cash flow | -9.59M | -18.47% |
About
Founded
Jan 1, 1996
Headquarters
Website
Employees
51
